These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29128836)

  • 1. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
    Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
    Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma.
    Thumrongsiri N; Dana P; Bawab R; Tanyapanyachon P; Treetidnipa C; Saengkrit N; Sathornsumetee S
    Biomed Pharmacother; 2022 Jun; 150():112979. PubMed ID: 35461090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma.
    Shi XX; Miao WM; Pang DW; Wu JS; Tong QS; Li JX; Luo JQ; Li WY; Du JZ; Wang J
    Biomater Sci; 2020 Mar; 8(5):1290-1297. PubMed ID: 31899467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
    Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
    World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression.
    Song L; Zhang W; Chen H; Zhang X; Wu H; Ma M; Wang Z; Gu N; Zhang Y
    Int J Nanomedicine; 2019; 14():921-936. PubMed ID: 30787607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
    Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
    Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
    Shi D; Mi G; Shen Y; Webster TJ
    Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma-Targeted Delivery of a Theranostic Liposome Integrated with Quantum Dots, Superparamagnetic Iron Oxide, and Cilengitide for Dual-Imaging Guiding Cancer Surgery.
    Xu HL; Yang JJ; ZhuGe DL; Lin MT; Zhu QY; Jin BH; Tong MQ; Shen BX; Xiao J; Zhao YZ
    Adv Healthc Mater; 2018 May; 7(9):e1701130. PubMed ID: 29350498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
    Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab.
    Azadbakht B; Afarideh H; Ghannadi-Maragheh M; Bahrami-Samani A; Asgari M
    Nucl Med Biol; 2017 May; 48():26-30. PubMed ID: 28189044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Oncological Hyperthermia: Physically Drivable Magnetic Nanobubbles as Novel Multipurpose Theranostic Carriers in the Central Nervous System.
    Ficiarà E; Ansari SA; Argenziano M; Cangemi L; Monge C; Cavalli R; D'Agata F
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of multifunctional Janus nanoparticles on the basis of SPIONs as targeted drug delivery system.
    Shaghaghi B; Khoee S; Bonakdar S
    Int J Pharm; 2019 Mar; 559():1-12. PubMed ID: 30664992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
    Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
    Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.